Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol TRIB2 contributors: mct/pgu - updated : 24-04-2017
HGNC name tribbles homolog 2 (Drosophila)
HGNC id 30809
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • three distinct domains, a proline-rich N-terminus
  • a serine/threonine kinase homology domain, kinase domain is essential for its function
  • variant catalytic loop sequences compared to conventional kinases that are necessary for its activity
  • a C-terminal COP1 binding domain
  • HOMOLOGY
    interspecies homolog to murine Trib2 (98.3pc)
    homolog to rattus Trib2 (98.0pc)
    Homologene
    FAMILY
  • protein kinase superfamily
  • CAMK Ser/Thr protein kinase family
  • Tribbles subfamily
  • CATEGORY regulatory , antigen
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,cytoskeleton
    basic FUNCTION
  • interacting with MAPK kinases and regulating activation of map kinases
  • uveitis-associated candidate autoantigen
  • potent novel regulator of monocyte biology, controlling the activation of these cells
  • regulate gene expression by modulation of protein kinase signaling pathways
  • regulate activation of a number of intracellular signalling pathways with roles extending from mitosis and cell activation to apoptosis and modulation of gene expression
  • repressor of FOXO transcription factors, that contributes to the malignant phenotype of melanoma cells
  • can bind both COP1 and CEBPA, leading to degradation of CEBPA
  • potential driver of lung tumorigenesis through a mechanism that involves downregulation of CEBPA
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binding partner and a negative regulator of selected MAPKs
  • can bind both RFWD2 and CEBPA, leading to degradation of CEBPA
  • TRIB2 associated-BTRC, RFWD2 and SMURF1 reduced TCF4/CTNNB1 expression, and these effects could be enhanced by TRIB2
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in acute myelogenous leukemia
    tumoral     --over  
    in primary human lung tumors and in non-small cell lung cancer cells
    Susceptibility to multiple sclerosis
    Variant & Polymorphism other
  • increasing the risk of multiple sclerosis
  • Candidate gene
    Marker
    Therapy target
  • may be a promising therapeutic target upon RNAi-mediated TRIB2 knockdown
  • SystemTypeDisorderPubmed
    cancer  
    functional regions that are essential to its oncogenic role provide the basis for developing inhibitors that will block TRIB functions in cancer
    cancer  
    may be a promising therapeutic target upon RNAi-mediated TRIB2 knockdown
    cancerhemopathy 
    represent useful therapeutic targets for the treatment of AML in patients with dys-regulated trb activity
    ANIMAL & CELL MODELS